Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy. [electronic resource]
Producer: 20191016Description: 113 p. digitalISSN:- 2051-1426
- Aged
- Antineoplastic Agents, Immunological -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Fatal Outcome
- Female
- Humans
- Ipilimumab -- adverse effects
- Leukocytosis -- chemically induced
- Melanoma -- drug therapy
- Nivolumab -- adverse effects
- Paraneoplastic Syndromes -- chemically induced
- Skin Neoplasms -- drug therapy
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.